MA39833B1 - Nouvelle utilisation du n,n-bis-2-mercaptoéthyl isophtalamide - Google Patents
Nouvelle utilisation du n,n-bis-2-mercaptoéthyl isophtalamideInfo
- Publication number
- MA39833B1 MA39833B1 MA39833A MA39833A MA39833B1 MA 39833 B1 MA39833 B1 MA 39833B1 MA 39833 A MA39833 A MA 39833A MA 39833 A MA39833 A MA 39833A MA 39833 B1 MA39833 B1 MA 39833B1
- Authority
- MA
- Morocco
- Prior art keywords
- bis
- novel use
- mercaptoethyl isophthalamide
- isophthalamide
- mercaptoethyl
- Prior art date
Links
- QZUPTXGVPYNUIT-UHFFFAOYSA-N isophthalamide Chemical compound NC(=O)C1=CC=CC(C(N)=O)=C1 QZUPTXGVPYNUIT-UHFFFAOYSA-N 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 229940072107 ascorbate Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1406115.4A GB2524831A (en) | 2014-04-04 | 2014-04-04 | New pharmaceutical use |
| PCT/GB2015/050999 WO2015150793A1 (en) | 2014-04-04 | 2015-03-31 | New use of n,n-bis-2-mercaptoethyl isophthalamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA39833A MA39833A (fr) | 2017-02-08 |
| MA39833B1 true MA39833B1 (fr) | 2018-04-30 |
Family
ID=50776843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39833A MA39833B1 (fr) | 2014-04-04 | 2015-03-31 | Nouvelle utilisation du n,n-bis-2-mercaptoéthyl isophtalamide |
Country Status (36)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202005057D0 (en) | 2020-04-06 | 2020-05-20 | Emeramed Ltd | New Use |
| CN114778234B (zh) * | 2022-03-18 | 2025-08-15 | 武汉新烽光电股份有限公司 | 一种用于微流控总磷测试的抗坏血酸溶液的保存方法及保存结构 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586600B2 (en) | 2000-12-06 | 2003-07-01 | University Of Kentucky Research Foundation | Multidentate sulfur-containing ligands |
| JP2011026204A (ja) * | 2007-11-26 | 2011-02-10 | Rei Furukawa | タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物 |
| US8950583B2 (en) * | 2008-12-06 | 2015-02-10 | Ermes Medical Company Limited | Method to remove heavy metals from a mammal |
| CN102612511A (zh) | 2009-09-28 | 2012-07-25 | 肯塔基大学研究基金会 | 用于从污染的环境中去除元素的含巯基化合物及其使用方法 |
| US8575218B2 (en) | 2009-09-28 | 2013-11-05 | The University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| US8426368B2 (en) | 2010-03-25 | 2013-04-23 | The University Of Kentucky Research Foundation | Method of ameliorating oxidative stress and supplementing the diet |
| US20110237776A1 (en) | 2010-03-25 | 2011-09-29 | Haley Boyd E | Aromatic compounds with sulfur containing ligands |
-
2014
- 2014-04-04 GB GB1406115.4A patent/GB2524831A/en not_active Withdrawn
-
2015
- 2015-03-31 MA MA39833A patent/MA39833B1/fr unknown
- 2015-03-31 ME MEP-2018-50A patent/ME03012B/me unknown
- 2015-03-31 NO NO15723546A patent/NO3125876T3/no unknown
- 2015-03-31 LT LTEP15723546.6T patent/LT3125876T/lt unknown
- 2015-03-31 MX MX2016012591A patent/MX2016012591A/es active IP Right Grant
- 2015-03-31 PL PL15723546T patent/PL3125876T3/pl unknown
- 2015-03-31 ES ES15723546.6T patent/ES2659174T3/es active Active
- 2015-03-31 SI SI201530158T patent/SI3125876T1/en unknown
- 2015-03-31 HU HUE15723546A patent/HUE036206T2/hu unknown
- 2015-03-31 HR HRP20180325TT patent/HRP20180325T1/hr unknown
- 2015-03-31 CA CA2944113A patent/CA2944113C/en active Active
- 2015-03-31 US US15/129,654 patent/US9782368B2/en active Active
- 2015-03-31 BR BR112016022880-4A patent/BR112016022880B1/pt active IP Right Grant
- 2015-03-31 PE PE2016001785A patent/PE20170586A1/es unknown
- 2015-03-31 PT PT157235466T patent/PT3125876T/pt unknown
- 2015-03-31 SG SG11201607478RA patent/SG11201607478RA/en unknown
- 2015-03-31 JP JP2016557313A patent/JP6474423B2/ja active Active
- 2015-03-31 NZ NZ724678A patent/NZ724678A/en unknown
- 2015-03-31 DK DK15723546.6T patent/DK3125876T3/en active
- 2015-03-31 RS RS20180210A patent/RS56905B1/sr unknown
- 2015-03-31 KR KR1020167030801A patent/KR102482699B1/ko active Active
- 2015-03-31 SM SM20180116T patent/SMT201800116T1/it unknown
- 2015-03-31 EA EA201692013A patent/EA032116B1/ru unknown
- 2015-03-31 AU AU2015242374A patent/AU2015242374B2/en active Active
- 2015-03-31 CN CN201580017210.4A patent/CN106132405B/zh active Active
- 2015-03-31 WO PCT/GB2015/050999 patent/WO2015150793A1/en not_active Ceased
- 2015-03-31 EP EP15723546.6A patent/EP3125876B8/en active Active
- 2015-03-31 UA UAA201611073A patent/UA119558C2/uk unknown
-
2016
- 2016-09-16 ZA ZA2016/06406A patent/ZA201606406B/en unknown
- 2016-09-25 IL IL248027A patent/IL248027B/en active IP Right Grant
- 2016-09-30 CL CL2016002499A patent/CL2016002499A1/es unknown
- 2016-09-30 EC ECIEPI201678100A patent/ECSP16078100A/es unknown
- 2016-10-01 SA SA516371966A patent/SA516371966B1/ar unknown
- 2016-10-04 PH PH12016501975A patent/PH12016501975A1/en unknown
-
2018
- 2018-02-09 CY CY20181100160T patent/CY1121235T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME03314B (me) | Irnk terapija za liječenje očnih oboljenja | |
| MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
| AR111693A1 (es) | Compuestos de 5-metil-1,3,4-oxadiazol-2-ilo con actividad inhibitoria de oga | |
| FI3452448T3 (fi) | Integroidun stressivastereitin modulaattoreita | |
| EP3525735A4 (en) | THERAPEUTIC ULTRASOUND FOR EYE DISEASES | |
| MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
| EP3019491A4 (en) | KINASEHEMMER FOR THE TREATMENT OF DISEASES | |
| EP3630964A4 (en) | THERAPEUTICS FOR GLYCOGEN STORAGE DISEASE OF TYPE III | |
| EA201791688A8 (ru) | Применение prg4 в качестве противовоспалительного средства | |
| EP3731847A4 (en) | PULSED ADMINISTRATION OF INHALED NITROGEN OXIDE FOR THE TREATMENT OF PULMONIC HYPERTENSION | |
| IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
| EP3324944A4 (en) | INTRAVITREAL AGGREGATION SYSTEMS FOR THE TREATMENT OF EYE DISEASE | |
| IL268693B (en) | Compounds for the treatment of glycogen storage disorders | |
| MA53568A (fr) | Médicaments pour le traitement de maladies ophtalmiques | |
| HRP20191121T1 (hr) | Tretman multiple skleroze | |
| MA43825A (fr) | Schémas posologiques pour le traitement d'infections fongiques | |
| LT3687567T (lt) | Anti-adrenomedulino rišiklis, skirtas panaudoti taikant ligos simptomų terapiją arba profilaktiką | |
| EP3405211A4 (en) | ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASES | |
| EP3407776A4 (en) | SIMPLIFIED INSTANCES OF VIRTUAL PHYSIOLOGICAL SYSTEMS FOR INTERNET-DONE-PROCESSING | |
| EA201992004A1 (ru) | Способы предотвращения или лечения офтальмологических заболеваний | |
| LT3458045T (lt) | Ebselenas, skirtas naudoti menjero ligos gydymui | |
| MA39833B1 (fr) | Nouvelle utilisation du n,n-bis-2-mercaptoéthyl isophtalamide | |
| CY1122418T1 (el) | Αγωγη ερυθρομελαλγιας | |
| EP3406258A4 (en) | MEDICINAL PRODUCT FOR USE IN THE TREATMENT OF GICHT | |
| MA44660A (fr) | (+)-azasetron destiné à être utilisé dans le traitement de troubles de l'oreille |